Effect of High-Dose and Low-Dose Statin for Coronary Plaque Modification.
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2016
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Myocardial ischaemia
- Focus Biomarker; Pharmacodynamics
- Acronyms STABLE
- 19 Apr 2016 Results published in the Journal of the American College of Cardiology
- 07 Aug 2012 Planned end date changed from 1 Apr 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 22 Apr 2011 Planned end date changed from 1 Mar 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.